20 November 2025

Eden Research Plc

("Eden" or "Company")

3LOGY Label Extension in Italy

3LOGY® has been approved in Italy for use across an additional range of new crops and a number of new disease targets.

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, is pleased to announce that 3LOGY (predominantly known as Mevalone® outside of Italy) has been granted approval by the Italian authorities for use on numerous new crops in order to control Botrytis and a range of new diseases, including powdery mildew and Sclerotinia. 

The label for 3LOGY has been expanded over time from a specialised fungicide for grey mould (Botrytis cinerea) in grapes to a broad-spectrum fungicide for multiple horticultural crops following its first label extension in Italy in 2022. Now a leading biofungicide in the Italian market, 3LOGY has efficacy on crops that require the highest quality standards, including leafy vegetables, table grapes, and kiwis. 

The new crops approved for 3LOGY include legumes (such as peas, lentils, and chickpeas) as well as other crops such as avocado, carrot, radish, celery and asparagus. This new approval extends the list of vegetables already approved for 3LOGY, making it one of the most versatile tools for all vegetable growers in Italy. Together, the new label extensions grow the addressable market in Italy by more than twenty thousand hectares and provide 3LOGY with the opportunity to play a key role in the sustainable cultivation of these high-value crops.

Sean Smith, CEO of Eden Research, commented:

"Eden's commercial partner, Sipcam Italia, has secured a further label extension for 3LOGY in Italy.  Beyond the enlarged addressable market in Italy, 3LOGY offers additional value for growers simply due to the extensive list of crops on which it can now be used. This versatility allows farmers to use it as a reference fungicide across cultivated open fields and in greenhouses for certain crops. 

This label extension reflects Eden's ongoing strategy to grow its core business through the addition of not only new products, but also through the expansion of regulatory authorisations for existing products that have substantial additional potential beyond simple territorial expansions."

Stefano Ciannamea, Product Manager at Sipcam Italia, commented:

"This label extension enhances our competitive position within the fungicide segment. Sipcam Italia and 3LOGY are now considered top-of-mind products for Italian growers in a market with limited options. Although the potential sales gains are difficult to quantify, we are positioning 3LOGY as the most reliable solution for farmers."

For further information contact:

Notes to Editors:

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has three products currently on the market:

Based on plant-derived active ingredients, Mevalone® is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops.  It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally.

Cedroz™ is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally.  Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.

Eden's seed treatment product, EcovelexÔ was developed to safely tackle crop destruction caused by birds - a major cause of losses in maize and other crops. Ecovelex works by creating an unpleasant taste or odour that repels birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. The product is based on Eden's plant-derived chemistry, registered in the EU, U.S. and elsewhere, and formulated using Eden's Sustaine® microencapsulation system.

Eden's Sustaine^® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.

For more information about Eden, please visit:  www.edenresearch.com.

Follow Eden on LinkedIn, Twitter and YouTube.